Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.250
-0.010 (-0.79%)
At close: Jan 6, 2026, 4:00 PM EST
1.270
+0.020 (1.60%)
After-hours: Jan 6, 2026, 6:52 PM EST
Celularity Market Cap
Celularity has a market cap or net worth of $35.6 million as of January 6, 2026. Its market cap has decreased by -28.03% in one year.
Market Cap
35.60M
Enterprise Value
102.53M
1-Year Change
-28.03%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $35.60M, a decrease of -89.89%. That is a compound annual growth rate of -30.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 35.88M | 13.51% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.48B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |